186 related articles for article (PubMed ID: 37660472)
1. The assessment of pathological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer patients with DCE-MRI and DWI: a systematic review and meta-analysis.
Zong R; Ma X; Shi Y; Geng L
Br J Radiol; 2023 Oct; 96(1150):20230239. PubMed ID: 37660472
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis.
Li Z; Li J; Lu X; Qu M; Tian J; Lei J
Eur J Radiol; 2021 Oct; 143():109931. PubMed ID: 34492627
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
[TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
Jun W; Cong W; Xianxin X; Daqing J
Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of contrast-enhanced dynamic and diffusion-weighted MR imaging in the assessment of tumor response to neoadjuvant therapy in muscle-invasive bladder cancer.
Ahmed SA; Taher MGA; Ali WA; Ebrahem MAES
Abdom Radiol (NY); 2021 Jun; 46(6):2712-2721. PubMed ID: 33547919
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
Tang S; Xiang C; Yang Q
Br J Radiol; 2020 Aug; 93(1112):20200301. PubMed ID: 32574075
[TBL] [Abstract][Full Text] [Related]
7. Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI.
Woo S; Becker AS; Das JP; Ghafoor S; Arita Y; Benfante N; Gangai N; Teo MY; Goh AC; Vargas HA
Cancer Imaging; 2023 Nov; 23(1):110. PubMed ID: 37964386
[TBL] [Abstract][Full Text] [Related]
8. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
9. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
An YY; Kim SH; Kang BJ; Lee AW
J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses.
Li B; Li Q; Chen C; Guan Y; Liu S
Acad Radiol; 2014 Jan; 21(1):21-9. PubMed ID: 24331261
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis.
Yang L; Tan Y; Dan H; Hu L; Zhang J
Acta Radiol; 2021 Sep; 62(9):1238-1247. PubMed ID: 32903025
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pathological complete response after neoadjuvant systemic treatment of invasive breast cancer using diffusion-weighted imaging compared with dynamic contrast-enhanced based kinetic analysis.
Ota R; Kataoka M; Iima M; Honda M; Ohashi A; Ohno Kishimoto A; Miyake KK; Yamada Y; Takeuchi Y; Toi M; Nakamoto Y
Eur J Radiol; 2022 Sep; 154():110372. PubMed ID: 35667297
[TBL] [Abstract][Full Text] [Related]
13. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
[TBL] [Abstract][Full Text] [Related]
14. The Diagnostic Performance of DCE-MRI in Evaluating the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis.
Cheng Q; Huang J; Liang J; Ma M; Ye K; Shi C; Luo L
Front Oncol; 2020; 10():93. PubMed ID: 32117747
[No Abstract] [Full Text] [Related]
15. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
16. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report.
Petrillo M; Fusco R; Catalano O; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A
Biomed Res Int; 2015; 2015():514740. PubMed ID: 26413528
[TBL] [Abstract][Full Text] [Related]
17. Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.
Xiong J; Luo J; Bian J; Wu J
Eur Radiol; 2022 Feb; 32(2):1285-1296. PubMed ID: 34357448
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of T2-weighted imaging and dynamic contrast-enhanced MRI for assessing cervical invasion in patients with endometrial cancer: a meta-analysis.
Bi Q; Chen Y; Chen J; Zhang H; Lei Y; Yang J; Zhang Y; Bi G
Clin Imaging; 2021 Oct; 78():206-213. PubMed ID: 34049140
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI versus FDG-PET/CT for diagnosing pancreatic cancer: an indirect comparison meta-analysis.
Que R; Chen Y; Tao Z; Ge B; Li M; Fu Z; Li Y
Acta Radiol; 2020 Nov; 61(11):1473-1483. PubMed ID: 32148066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
